Information in summaries of product characteristics about use in children is limited and needs standardisation: a systematic analysis in Switzerland.
Romy TilenChristoph BergerSamuel AllemannHenriette Meyer Zu SchwabedissenPublished in: Archives of disease in childhood (2024)
Most Swiss SmPCs contain information about children, but only a minority refer to an official indication. Even if some SmPCs clearly indicate that use in children is authorised, a clear statement of the age at which the drug may be administered is missing. Standardisation of information about use in children in SmPCs is needed.